Lombard Odier Transatlantic’s Bristol-Myers Squibb BMY Stock Holding History

Lombard Odier Transatlantic’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$27K	Hold	500	–	–	0.03%	119
2016 Q2	$37K	Sell	500 -500	-50%	-$35.3K	0.04%	96
2016 Q1	$64K	Hold	1,000	–	–	0.06%	80
2015 Q4	$69K	Hold	1,000	–	–	0.06%	82
2015 Q3	$59K	Hold	1,000	–	–	0.06%	75
2015 Q2	$67K	Hold	1,000	–	–	0.06%	80
2015 Q1	$65K	Hold	1,000	–	–	0.05%	95
2014 Q4	$59K	Buy	+1,000	New	+$56.4K	0.05%	89

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Lombard Odier Transatlantic's BMY Position: Q3 2016 in Review

Lombard Odier Transatlantic held its Bristol-Myers Squibb (BMY) position steady in Q3 2016 at 500 shares worth $27K. The position accounts for 0.03% of the portfolio, ranked #119.

Lombard Odier Transatlantic first reported a position in BMY in Q4 2014 and has held it in 8 quarters since. The position peaked at $69K in Q4 2015. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Lombard Odier Transatlantic held 500 shares of Bristol-Myers Squibb worth $27K as of Q3 2016.
Lombard Odier Transatlantic left its Bristol-Myers Squibb share count unchanged in Q3 2016.
Bristol-Myers Squibb made up 0.03% of Lombard Odier Transatlantic's portfolio in Q3 2016, its #119 holding.
Lombard Odier Transatlantic first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 8 quarters since.
Lombard Odier Transatlantic's Bristol-Myers Squibb position peaked at $69K in Q4 2015.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Lombard Odier Transatlantic's 13F filing for Q3 2016, filed 14 Nov 2016.